The ef="http://www.morningstar.co.uk/uk/snapshot/snapshot.aspx?tab=10&id=F0GBR04HGX"> full four page PDF report can be accessed here. It is free to users of morningstar.co.uk
The ef="http://www.morningstar.co.uk/uk/snapshot/snapshot.aspx?tab=10&id=F0GBR04HGX"> full four page PDF report can be accessed here. It is free to users of morningstar.co.uk
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.
Sales of Wegovy and Ozempic soar but shares fall on concerns about lower prices and competition f...
Analyst Mathieu Caquineau explains why more and more fund managers are cutting headcount
UPDATED: Anglo American and Plus500 are among April 2024's high-yielding winners
New buyback is worth $3.5 billion, the same as the past two quarters, and the dividend is up 20%
Federal Reserve sees a lack of progress in inflation battle but says that monetary policy is suff...
Mining companies are operating in a challenging environment but could now be the time to top up o...
THE WEEK: Morningstar columnist Rodney Hobson provides two pieces of advice to George Osborne, an...
Businesses that have competitive advantages within their industry are good candidates for dividen...
Morningstar reveals the top 10 best performers over the last five years
Morningstar OBSR reveals the top funds for investors seeking exposure to European equities
Sales of Wegovy and Ozempic soar but shares fall on concerns about lower prices and competition f...
Analyst Mathieu Caquineau explains why more and more fund managers are cutting headcount
UPDATED: Anglo American and Plus500 are among April 2024's high-yielding winners
New buyback is worth $3.5 billion, the same as the past two quarters, and the dividend is up 20%
Federal Reserve sees a lack of progress in inflation battle but says that monetary policy is suff...
Mark Laidlaw Mark Laidlaw is a senior analyst, manager research for Morningstar.